http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2000169391-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_74fa5a9700ef5f525e1b6f75b4e30e6b
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-02
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-183
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-57
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-02
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-36
filingDate 1999-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f7c03abf0b9b166831fb093a6663927f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1b14a2267ade8f61f5432d6d55624cf0
publicationDate 2000-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2000169391-A
titleOfInvention Stabilized antithrombin III preparation
abstract PROBLEM TO BE SOLVED: To provide a stabilized antithrombin II protected from loss of activity during pasteurization by adding a stabilizer Provision of I preparations. SOLUTION: a) One or more saccharides or b) One or more amino acids selected from the group consisting of arginine, lysine, histidine, phenylalanine, tryptophan, tyrosine, aspartic acid and salts thereof, or glutamic acid and salts thereof. 0.5 mol / Protection from loss of activity during pasteurization by the addition of a stabilizer consisting of one or more saccharides, together with liters or, optionally, additionally of each of these amino acids, further added with glycine or glutamine. Thus, a stabilized antithrombin III preparation is obtained.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2007222169-A
priorityDate 1998-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9003784-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S5495715-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6305
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP01008
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399382
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP32261
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395485
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399383
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP32262
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395486
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226398727
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID994
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226398728
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ5R5A3
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID232
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ03352
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID773
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1148
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP81050
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394420
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6140
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP41361
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID462
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID540261
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6274
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID304917
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID11905

Total number of triples: 52.